Based on these studies, the harmful effect of FGF23 on the cardiovascular system led to our advanced understanding that FGF23 is not only a signal transducer to handle phosphate handling, but also a feasible biomarker for CVD and all-cause mortality in the CKD population. This evidence concerns the gene FGF23 and chronic kidney disease.